Welcome to our dedicated page for Ameren SEC filings (Ticker: AEE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Digging through Ameren’s 300-page disclosures for fuel-mix data or the latest Missouri rate decision can feel impossible. Utility filings weave dense regulatory language with engineering terms, so even seasoned analysts struggle to spot how storm-cost deferrals or grid-modernization spending will affect future returns.
Stock Titan solves that problem. Our AI reads every Ameren SEC document the moment it appears on EDGAR, then surfaces what matters: a one-paragraph summary of each 10-K annual report, variance highlights inside the Ameren quarterly earnings report 10-Q filing, and plain-English explanations of any 8-K material events—from rate-case rulings to unexpected generation outages. You can also monitor Ameren insider trading Form 4 transactions in real time, complete with context on executive roles and historical buying patterns.
Need specifics? Use our platform to:
- Track Ameren Form 4 insider transactions real-time before they hit the news cycle.
- See which business segment drives earnings in the latest 10-Q—without scrolling hundreds of pages.
- Compare executive pay packages inside the proxy statement executive compensation section, side-by-side with peer utilities.
- Get an AI-generated checklist pointing to carbon-transition cap-ex buried in footnotes.
Whether you’re asking, "How do I read Ameren’s 10-K?", searching for "Ameren SEC filings explained simply", or looking to decode the next rate-case 8-K, our platform delivers clear answers and time-saving insight that help you make informed decisions.
T. Rowe Price Investment Management, Inc. reports a material passive stake in Ameren Corporation, holding 14,362,684 shares, equal to 5.2% of the common stock. The filer discloses sole voting power for 13,437,982 shares and sole dispositive power for all 14,362,684 shares, with no shared voting or dispositive authority. The Schedule 13G classification and the filer’s certification indicate these shares are held in the ordinary course of business and are not reported as intended to change or influence control. The filing clarifies ownership magnitude and voting authority without announcing any change in control.
Transaction summary: Michael L. Moehn, Sr Executive VP & CFO of Ameren Corporation (AEE), reported a sale of 6,500 shares of Ameren common stock on 08/01/2025 at $102.54 per share. Following the reported transaction, Mr. Moehn beneficially owns 204,879 shares directly. He also holds 5,147 share equivalents indirectly in the Ameren Savings Investment Plan unitized stock fund as of 07/31/2025.
Filing notes: The Form 4 was dated and signed by Jonathan T. Shade as attorney-in-fact on 08/05/2025. The filing states that the reported direct total includes 611 accrued dividend equivalents acquired in Q2 2025 pursuant to dividend reinvestment of restricted stock units under the issuer's 2022 Omnibus Incentive Compensation Plan. No derivative transactions were reported on this form.
Ameren Corp. (AEE) filed a Form 144 covering a planned insider sale of 6,500 common shares through Fidelity Brokerage Services on or about 01 Aug 2025. At the filing’s reference price, the block is valued at � $666,510. The shares stem from restricted-stock vesting on 01 Mar 2025 and were received as compensation, not purchased for cash.
The seller, Michael Moehn (address disclosed), previously sold an identical 6,500-share lot on 20 May 2025 for $641,030. Ameren reports 270,278,917 shares outstanding, so the proposed sale represents roughly 0.0024 % of the float—an immaterial level for dilution and ownership concentration. The filer affirms no knowledge of undisclosed adverse information and, if applicable, compliance with Rule 10b5-1 trading-plan requirements.
Given the limited size, routine compensation origin and absence of other transactional details, the notice appears administrative with negligible capital-market impact.